What Capital Wholesale Drug Company does

Capital Wholesale Drug Company (operating as Capital Drug) is a family-owned pharmaceutical wholesaler and full-line drug distributor founded in 1950 in Columbus, Ohio. The company purchases generic and branded pharmaceuticals directly from manufacturers and distributes them to independent pharmacies, government healthcare organizations, hospital systems, and university healthcare clinics across the lower 48 U.S. states (excluding Alaska and Hawaii). It holds NABP Drug Distributor Accreditation, is a member of the Healthcare Distribution Alliance (HDA), and operates under a regulatory license footprint covering 48 states.

The company's product portfolio centers on DSCSA (Drug Supply Chain Security Act) compliance infrastructure layered on top of its core distribution business. Its primary products are Capital Drug 360, a comprehensive DSCSA compliance subscription solution for dispensing pharmacies that enables trading partner verification and serialized product data ingestion from suppliers, and the DSCSA Traceability Portal, an EPCIS transaction document repository built on OneScan from Lspedia that allows customers to store and download serialized transaction data. Back-office operations rely on electronic data interchange (EDI), AS2, FTP, and web service integrations with trading partners rather than a public API. The technology platform is positioned as a compliance utility rather than a differentiated analytics or AI product.

Capital Drug operates a sales-led, B2B go-to-market with dedicated account representatives providing personalized service and daily customer interaction, complemented by a self-service online ordering portal (order.capital-drug.com) for existing customers. Pricing is negotiated and quote-based rather than publicly disclosed, and revenue is generated through transactional pharmaceutical distribution margins. The business is privately held under continuous Richards family ownership across three generations, with no external investors disclosed prior to a 2024 senior credit facility from Huntington National Bank. Marketing channels are limited to direct sales, HDA participation, company website/blog content, and industry event presence.

Name

Capital Wholesale Drug Company

Legal name

Capital Wholesale Drug Company

Website

https://capital-drug.com

Company type

Private

Founded year

1950

Operating status

Operating

Headcount range

51–100 employees

Short description

Capital Wholesale Drug Company is a family-owned, NABP-accredited pharmaceutical wholesaler founded in 1950 that distributes generic and branded drugs directly from manufacturers to independent pharmacies, hospitals, government facilities, and university clinics across 48 U.S. states, with DSCSA compliance tooling layered on top of distribution.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industries

Retail Pharmacy Supply Wholesalers (HLAIAJAE), Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD), Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)

Keywords

• Pharmaceutical distribution
• Drug wholesale services
• DSCSA compliance solutions
• Generic pharmaceuticals supply
• Pharmaceutical logistics

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Wholesale Distribution: Revenue generated from the sale and distribution of pharmaceutical products, both generic and branded, purchased directly from manufacturers and sold to dispensing pharmacies and healthcare providers. The company operates as a full-line independent wholesaler serving the lower 48 states.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Capital Wholesale Drug Company is a licensed pharmaceutical wholesaler that purchases generic and branded drugs directly from manufacturers and distributes them to independent pharmacies, government organizations, hospital systems, and university healthcare clinics across the lower 48 U.S. states. The company supplements its core distribution business with DSCSA compliance solutions, including the Capital Drug 360 platform and a OneScan-powered EPCIS traceability portal that help dispensing pharmacies meet Drug Supply Chain Security Act requirements.

Product overview

Capital Wholesale Drug Company operates as a family-owned pharmaceutical wholesaler offering a portfolio centered on DSCSA compliance solutions and full-line drug distribution. The core offerings include Capital Drug 360 (a comprehensive DSCSA compliance platform for dispensing pharmacies) and the DSCSA Traceability Portal powered by OneScan/Lspedia (for EPCIS transaction document management). These are complemented by the company's primary business of pharmaceutical wholesaling, purchasing direct from generic and branded manufacturers to serve independent pharmacies, government organizations, hospital systems, and university healthcare clinics across the lower 48 states.

Differentiator

Problem solved

Functional benefit

Products and services

• Capital Drug 360 A comprehensive DSCSA (Drug Supply Chain Security Act) compliance subscription solution for dispensing pharmacies that helps customers verify trading partners, receive serialized product data from all suppliers, and maintain regulatory compliance.
• DSCSA Traceability Portal (OneScan/Lspedia) An EPCIS transaction document repository powered by OneScan/Lspedia that lets Capital Drug customers sign in or register to store and download serialized transaction data (EPCIS documents) for shipments from Capital Drug, supporting DSCSA traceability requirements.
• Pharmaceutical Wholesaling Services Full-line pharmaceutical distribution services purchasing direct from both generic and branded manufacturers, serving independent pharmacies, government organizations, hospital systems, and university healthcare clinics across the lower 48 U.S. states, supported by dedicated account representatives and an online ordering portal.

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature2 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Tremont PharmacyminorOthersLong-term customer partnership spanning decades. Tremont Pharmacy, a local independent pharmacy in Columbus, Ohio, has worked with Capital Drug for many years. Following the approval of COVID-19 vaccines, they provided vaccinations for all Capital Drug employees, demonstrating the close relationship between family-owned businesses.
• Lspedia (OneScan)coreTechnology or IntegrationTechnology partnership providing the DSCSA Traceability Portal for Capital Drug customers. The OneScan platform serves as the EPCIS transaction document repository allowing customers to store and download serialized transaction data for shipments from Capital Drug. The portal enables DSCSA compliance through verification of trading partners.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Morris & Dickson Co., LLC: One of the largest independent U.S. pharmaceutical wholesalers, focused on full-line distribution to independent retail pharmacies and hospitals across a multi-state footprint — directly comparable business model, customer base, and regulatory profile to Capital Drug.
• Smith Drug Company: Independent pharmaceutical wholesaler headquartered in South Carolina, serving independent pharmacies, institutions, and health systems with full-line generic and branded distribution — closely mirrors Capital Drug's independent-pharmacy-led, full-line model.
• Value Drug Company: Pennsylvania-based independent wholesaler serving independent retail pharmacies across multiple states with full-line branded and generic distribution and value-added services — same target customer and product breadth as Capital Drug.
• Rochester Drug Cooperative: Member-owned pharmaceutical wholesaler serving independent pharmacies, hospitals, and long-term care providers in the Northeast; comparable cooperative/independent distribution model targeting similar pharmacy customers.
• Mutual Drug: Member-owned wholesale cooperative serving independent pharmacies across the Carolinas and Southeast; directly comparable independent-pharmacy-focused distribution model with similar customer-relationship-driven GTM.

Broad incumbents

• McKesson Corporation: Largest U.S. pharmaceutical wholesaler offering full-line distribution plus broad specialty, biopharma services, and technology; competes with Capital Drug across most customer segments and sets the pricing baseline for generic and branded procurement.
• Cencora (formerly AmerisourceBergen): Top-3 global pharmaceutical distributor with extensive U.S. retail, hospital, specialty, and animal-health distribution; competing incumbent across all of Capital Drug's served segments including independent pharmacy programs (e.g., Good Neighbor Pharmacy).
• Cardinal Health: Top-3 U.S. pharmaceutical wholesaler with at-scale retail, hospital, and specialty distribution; competing incumbent that has absorbed independent wholesalers (e.g., Kinray), directly pressuring independents like Capital Drug.
• Anda, Inc. (Teva Pharmaceutical Industries): Generic-focused pharmaceutical distributor and Teva subsidiary distributing to retail pharmacies, hospitals, and chains nationwide; comparable full-line generic distribution capability and a relevant alternative procurement channel for Capital Drug's customer base.

Emerging players

• H.D. Smith (now part of Cencora): Was the largest privately held U.S. pharmaceutical wholesaler before its acquisition by AmerisourceBergen/Cencora; representative of the consolidation pathway facing independent wholesalers like Capital Drug.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Capital Wholesale Drug Company